FDA CONSUMER HEALTH INFORMATION - March 15 Webinar: Tattoos and Permanent Makeup

Mar 10, 2011, 14:08 ET from U.S. Food and Drug Administration

SILVER SPRING, Md., March 10, 2011 /PRNewswire-USNewswire/ -- Are tattoos and permanent makeup safe?

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

Learn about the inks and pigments used in tattoos and permanent makeup during a 30-minute webinar hosted by the Food and Drug Administration's Office of Cosmetics and Colors. An FDA expert will talk about problems that have occurred with the use of these inks, such as allergic reactions, infections, and scarring, and will address FDA's response to these occurrences. Misrepresentation of these inks and pigments as "FDA approved" will also be discussed.

The public will have an opportunity to ask questions following the presentation.

When:  Tuesday, March 15 at 2:00 p.m. (ET)

Length: 30 minutes

Where: To join the webinar, see the instructions at http://www.fda.gov/AboutFDA/Transparency/Basics/ucm246155.htm

Host: Office of Cosmetics and Colors in FDA's Center for Food Safety and Applied Nutrition

Featured speaker: Bhakti Petigara Harp, Ph.D., of the Office of Cosmetics and Colors, Division of Color Certification and Technology, in FDA's Center for Food Safety and Applied Nutrition.

This webinar is part of a series of online sessions hosted by different FDA centers and offices. The series is part of FDA Basics, a Web-based resource aimed at helping the public better understand what the agency does.

Sign up for e-mail notices of new FDA Consumer Updates at https://service.govdelivery.com/service/subscribe.html?code=USFDA_9

View the FDA Consumer Update RSS feed at http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/Consumers/rss.xml

FDA Consumer Updates may be posted and published elsewhere without permission. Please credit "FDA Consumer Health Information (www.fda.gov/consumer)" as the source. FDA values feedback on its consumer health information. Send questions, comments, or story ideas to: consumerinfo@fda.hhs.gov.

CONTACT: Jason Brodsky, +1-301-796-8234, jason.brodsky@fda.hhs.gov

SOURCE U.S. Food and Drug Administration



RELATED LINKS

http://www.fda.gov/